Takeda Pharmaceutical Co Ltd (4502.T)
22 Feb 2017
Mon, Feb 20 2017
* Says the co plans to transfer domestic consumer healthcare business to its wholly owned unit, a Tokyo-based medical supplies firm
* Says co completes full acquisition of ARIAD Pharmaceuticals Inc on Feb. 16(U.S. local time), at $24.00 per share
* Says PRA Health Sciences Inc and Takeda Pharmaceutical Company Limited have agreed to a new partnership to expand their global relationship initially disclosed in September 2016 to include Japan
A federal appeals court has refused to revive Takeda Pharmaceutical Co and its hedge fund investor Elliott Associates' bid to block Hikma Pharmaceuticals PLC from selling its gout drug Mitigare.
A federal appeals court on Wednesday revived claims by health plans accusing Takeda Pharmaceuticals of delaying generic versions of its blockbuster diabetes drug Actos by misrepresenting patents it had on the drug.
A lawyer for Japanese drugmaker Takeda Pharmaceuticals Co on Monday urged a federal appeals court to revive a patent on its top-selling cancer drug Velcade, which faces generic competition later this year.
TOKYO, Feb 1 Japan's largest drugmaker, Takeda Pharmaceuticals Co, on Wednesday said it would maintain its pricing model in the U.S. market, brushing off demands by U.S. President Donald Trump for drugmakers to offer cheaper drugs.
TOKYO Japan's largest drugmaker, Takeda Pharmaceuticals Co, on Wednesday said it would maintain its pricing model in the U.S. market, brushing off demands by U.S. President Donald Trump for drugmakers to offer cheaper drugs.
BRIEF-Takeda Pharmaceutical and Shionogi & Co to develop treatment techniques to combat Dementia- Nikkei
* Takeda Pharmaceutical and Shionogi & Co. with three other Japanese drug companies to develop treatment techniques to combat Dementia
Hikma Pharmaceuticals PLC is fighting back against a bid by Takeda Pharmaceutical Co and its hedge fund investor Elliott Associates to revive a case in a Washington, D.C. federal appeals court in order to block Hikma from selling its gout drug Mitigare.